Xuan J. Wang

512 total citations
12 papers, 342 citations indexed

About

Xuan J. Wang is a scholar working on Pathology and Forensic Medicine, Genetics and Neurology. According to data from OpenAlex, Xuan J. Wang has authored 12 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 4 papers in Neurology. Recurrent topics in Xuan J. Wang's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (3 papers). Xuan J. Wang is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (3 papers). Xuan J. Wang collaborates with scholars based in United States. Xuan J. Wang's co-authors include Shaoying Li, L. Jeffrey Medeiros, Pei Lin, Guilin Tang, Parth Desai, Roberto N. Miranda, Joseph D. Khoury, Nishitha Reddy, Adam C. Seegmiller and C. Cameron Yin and has published in prestigious journals such as New England Journal of Medicine, Blood and The American Journal of Surgical Pathology.

In The Last Decade

Xuan J. Wang

12 papers receiving 334 citations

Peers

Xuan J. Wang
Axel Nolting Germany
M Kanda Japan
Bassam N. Smir United States
Sheryl L. Asplund United States
M. Group United States
Khaled Alayed Saudi Arabia
Jeremy Ramdial United States
Erik L. Kimble United States
Axel Nolting Germany
Xuan J. Wang
Citations per year, relative to Xuan J. Wang Xuan J. Wang (= 1×) peers Axel Nolting

Countries citing papers authored by Xuan J. Wang

Since Specialization
Citations

This map shows the geographic impact of Xuan J. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan J. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan J. Wang more than expected).

Fields of papers citing papers by Xuan J. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan J. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan J. Wang. The network helps show where Xuan J. Wang may publish in the future.

Co-authorship network of co-authors of Xuan J. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan J. Wang. A scholar is included among the top collaborators of Xuan J. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan J. Wang. Xuan J. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wang, Xuan J., et al.. (2021). Light Chain–Restricted Plasmacytoid Cells in Hyperplastic Germinal CentersA Clinicopathologic Investigation. American Journal of Clinical Pathology. 156(5). 871–885. 4 indexed citations
2.
Wang, Xuan J., L. Jeffrey Medeiros, Carlos E. Bueso‐Ramos, et al.. (2016). P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma. Modern Pathology. 30(2). 194–203. 65 indexed citations
3.
Wang, Xuan J., Gabriel K. Griffin, Ashwini Yenamandra, et al.. (2016). Transformation of follicular lymphoma into classical Hodgkin lymphoma showing t(14;18). 1(1). 2 indexed citations
4.
5.
Li, Shaoying, Vivian Weiß, Xuan J. Wang, et al.. (2015). High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. The American Journal of Surgical Pathology. 40(2). 253–261. 37 indexed citations
6.
Wang, Xuan J., Adam C. Seegmiller, Nishitha Reddy, & Shaoying Li. (2015). CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B‐cell lymphoma. European Journal Of Haematology. 97(1). 39–47. 15 indexed citations
7.
Li, Shaoying, Parth Desai, Pei Lin, et al.. (2015). MYC/BCL6 double‐hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis. Histopathology. 68(7). 1090–1098. 73 indexed citations
8.
Li, Shaoying, Adam C. Seegmiller, Pei Lin, et al.. (2014). B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas. Modern Pathology. 28(2). 208–217. 60 indexed citations
9.
Wang, Xuan J., et al.. (2014). Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.. PubMed. 7(7). 4323–8. 10 indexed citations
10.
Wang, Xuan J., et al.. (2013). Intracortical schwannoma of the femur. Skeletal Radiology. 43(5). 687–691. 8 indexed citations
11.
Wang, Xuan J., Nishitha Reddy, & Shaoying Li. (2013). MYC Gene Single Hit Diffuse Large B Cell Lymphoma Behaves Similarly To MYC/BCL2 Double Hit Lymphoma and Needs Similar Aggressive Treatment. Blood. 122(21). 4313–4313. 1 indexed citations
12.
Pettit, April C., Jonathan A. Kropski, Jessica L. Castilho, et al.. (2012). The Index Case for the Fungal Meningitis Outbreak in the United States. New England Journal of Medicine. 367(22). 2119–2125. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026